Systematic review: early infant feeding and the prevention of coeliac disease
Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia
Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype
Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis – a post hoc analysis of 5796 patients
Gastric carcinoids after long-term use of a proton pump inhibitor
Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease
Is the subjective perception of lactose intolerance influenced by the psychological profile?
Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit
Commentary: predicting survival in hepatocellular carcinoma patients
Commentary: predicting survival in hepatocellular carcinoma patients – authors’ reply
Commentary: comparisons of upper gastrointestinal bleeding mortality by admission time
Commentary: time to update the ALT cut-off?
Letter: are we ready to dismiss use of enteral nutrition in cirrhotic patients with jaundice?
Letter: are we ready to dismiss use of enteral nutrition in cirrhotic patients with jaundice? Authors’ reply
Letter: real-life management of new onset ulcerative colitis and proctitis
Letter: real-life management of new onset ulcerative colitis and proctitis – authors’ reply
Letter: non-cirrhotic portal hypertension and end-stage liver disease
Letter: non-cirrhotic portal hypertension and end-stage liver disease – authors’ reply
Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function
Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function – author's reply